Particle Filtration Efficiency Testing of Sterilization Wrap Masks

ObjectivesNon-traditional materials are used for mask construction to address personal protective equipment shortages during the coronavirus disease 2019 (COVID-19) pandemic. Reusable masks made from surgical sterilization wrap represent such an innovative approach with social media frequently referring to them as “N95 alternatives.” This material was tested for particle filtration efficiency and breathability to clarify what role they might have in infection prevention and control.MethodsA heavyweight, double layer sterilization wrap was tested when new and after 2, 4, 6, and 10 autoclave sterilizing cycles and compared with an approved N95 respirator and a surgical mask via testing procedures using a sodium chloride aerosol for N95 efficiency testing similar to 42 CFR 84.181. Pressure testing to indicate breathability was also conducted.ResultsThe particle filtration efficiency for the sterilization wrap ranged between 58% to 66%, with similar performance when new and after sterilizing cycles. The N95 respirator and surgical mask performed at 95% and 68% respectively. Pressure drops for the sterilization wrap, N95 and surgical mask were 10.4 mmH₂O, 5.9 mmH₂O, and 5.1 mmH₂O, respectively, well below the National Institute for Occupational Safety and Health limits of 35 mmH₂O during initial inhalation and 25 mmH₂O during initial exhalation.ConclusionsThe sterilization wrap’s particle filtration efficiency is much lower than a N95 respirator, but falls within the range of a surgical mask, with acceptable breathability. Performance testing of non-traditional mask materials is crucial to determine potential protection efficacy and for correcting misinterpretation propagated through popular media.     

Randomized Comparison of Actual and Ideal Body Weight for Size Selection of the Laryngeal Mask Airway Classic in Overweight Patients

Size selection of the laryngeal mask airway (LMA) Classic based on actual body weight remains a common practice. However, ideal body weight might allow for a better size selection in obese patients. The purpose of our study was to compare the utility of ideal body weight and actual body weight when choosing the appropriate size of the LMA Classic by a randomized clinical trial. One hundred patients with age 20 to 70 yr, body mass index ≥25 kg/m², and the difference between LMA sizes based on actual weight and ideal weight were allocated to insert the LMA Classic using either actual body weight or ideal body weight in a weight-based formula for size selection. After insertion of the device, several variables including insertion parameters, sealing function, fiberoptic imaging, and complications were investigated. The insertion success rate at the first attempt was lower in the actual weight group (82%) than in the ideal weight group (96%), even it did not show significant difference. The ideal weight group had significantly shorter insertion time and easier placement. However, fiberoptic views were significantly better in the actual weight group. Intraoperative complications, sore throat in the recovery room, and dysphonia at postoperative 24 hr occurred significantly less often in the ideal weight group than in the actual weight group. It is suggested that the ideal body weight may be beneficial to the size selection of the LMA Classic in overweight patients (Clinical Trial Registry, {"type":"clinical-trial","attrs":{"text":"NCT 01843270","term_id":"NCT01843270"}}NCT 01843270).

Graphical Abstract

相似文献   

鼻咽通气道-面罩自主呼吸下丙泊酚-芬太尼-七氟醚静吸复合全麻用于小儿短小手术的效果:与喉罩自主呼吸的比较

目的 比较鼻咽通气道-面罩和喉罩自主呼吸下丙泊酚-芬太尼-七氟醚静吸复合全麻用于小儿短小手术的效果.方法 择期腹股沟斜疝高位结扎术患儿72例,采用随机数字表法,将患儿分为2组(n=36):鼻咽通气道-面罩组(M组)和喉罩组(L组).静脉注射丙泊酚1.0 mg/kg和芬太尼2.0μg/kg,保留自主呼吸,意识消失后扣上面罩,吸入2 L/min氧气和3％七氟醚,BIS值50 ～ 60时,L组置入2号喉罩,M组经左鼻腔置入鼻咽通气道并扣紧面罩,连接麻醉机行紧闭循环自主呼吸,切皮前5 min静脉注射芬太尼1 μg/kg,术中吸入七氟醚,维持BIS值40 ～ 60.于麻醉诱导前、麻醉诱导后3min、成功置入喉罩或鼻咽通气道即刻、切皮即刻、切皮后3 min、拔出喉罩或鼻咽通气道即刻测定MAP、HR、PETCO2和SpO2,记录置入喉罩或鼻咽通气道的时间和成功情况、苏醒时间、离开手术室时间及不良反应发生情况.结果 与L组比较,插管、拔管时M组MAP、HR降低,置入鼻咽通道时间较短且一次性置入成功率(100％)明显升高,患儿躁动评分及拔管后上呼吸道梗阻发生率明显降低(P＜0.05).结论 鼻咽通气道-面罩自主呼吸下丙泊酚-芬太尼-七氟醚静吸复合全麻用于小儿短小手术,易于建立人工通气道并可维持自主呼吸,对循环功能影响轻微,还可明显减少麻醉恢复期并发症的发生,其效果优于喉罩自主呼吸方式.     

无创正压通气治疗重症手足口病40例疗效观察

目的 探讨无创正压通气治疗重症手足口病的效果。方法 将2014年4月至2015年10月徐州市儿童医院收治的68例重症手足口病病儿作为研究对象,其中观察组40例应用无创正压通气治疗,对照组28例使用面罩或鼻导管给氧治疗,观察比较两组病儿临床疗效、血清脑钠肽水平、退热时间、心率及血压恢复正常所用时间。结果 观察组总有效率为82.5%,高于对照组的60.7%,差异有统计学意义(P＜0.05);观察组退热时间为(3.30±1.07)d,心率恢复正常所用时间为(3.50±1.09)d,血压恢复正常所用时间为(3.37±1.17)d,均短于对照组(P＜0.01);治疗24 h后观察组脑钠肽水平较对照组显著下降(P＜0.01)。结论 重症手足口病病儿在综合治疗的基础上早期进行无创正压通气治疗,可加快生命体征的各项指标恢复正常,提高治疗有效率。     

喉罩联合高频喷射通气在输尿管软镜钬激光碎石术麻醉中的应用

目的评价喉罩联合高频喷射通气应用于输尿管软镜钬激光碎石术的安全性。方法60例拟行输尿管软镜钬激光碎石患者,丙泊酚靶控输注静脉全麻后置入合适喉罩,联合高频喷射通气,比较通气前后平均动脉压（MAP）、心率（HR）、脉搏血氧饱和度（SpO2）、呼末二氧化碳分压（PET CO2）,动脉氧分压（PaO2）、动脉二氧化碳分压（PaCO2）、气道压（Paw）等参数。结果输尿管软镜钬激光碎石术采用丙泊酚靶控输注静脉全麻,置入喉罩联合高频喷射通气,PETCO2、PaCO2、Paw、分别由高频喷射通气前的（32.01±3.31）mmHg,（40.83±2.68）mm-Hg,（14.7±1.74）cmH2O 下降至通气后的（22.07±3.31）mmHg,（33.3±2.29）mmHg,（4.6±1.59）cmH2O;PaO2由（279.7±51.5）mmHg增至（311.78±46.4）mmHg。结论全凭静脉麻醉,采用喉罩联合高频喷射通气,能安全地应用于输尿管软镜钬激光碎石术。     

面罩机械通气抢救新生儿呼吸衰竭的疗效与评价

目的探索无创通气治疗新生儿呼吸衰竭的可行性并评价其疗效。方法将2004年7月～2005年12月新生儿重症监护室接受面罩机械通气治疗的新生儿24例作为治疗组,选择2003年1月～2004年6月22例同等病情并采用常规气管插管机械通气治疗的新生儿作为对照组,观察两组疗效。结果治疗组机械通气时间为(35.2±19.8)h,发生呼吸机相关性肺炎者2例,抢救成功者为21例,对照组机械通气时间为(49.1±22.4)h,发生呼吸机相关性肺炎者10例,抢救成功者为13例,两组以上指标间差别均有显著性意义(P<0.05)。结论面罩机械通气较气管插管机械通气治疗新生儿呼吸衰竭的临床效果较好。     

慢性阻塞性肺病病人术后无创正压通气的临床研究

目的比较术后常规治疗(SMT)加无创正压通气(NPPV)和单独应用常规治疗对伴有中、重度呼吸功能不全的慢性阻塞性肺病人的疗效。方法择期上腹部和胸腔手术病人24例，术前检查有慢性阻塞性肺病合并中度和重度呼吸功能不全，随机分成2组。对照组术后常规吸氧、静注氨茶碱、雾化吸入α     

双水平气道正压通气治疗急性左心衰的临床研究

目的评价双水平气道正压通气(BiPAP)无创机械通气对急性左心衰患者的临床疗效。方法将64例急性左心衰患者随机分为两组(BiPAP组和对照组),BiPAP组在常规治疗的基础上,给予BiPAP呼吸机经鼻面罩双水平气道正压通气治疗;对照组在常规药物治疗的基础上,给予面罩高流量吸氧。观察两组治疗前后血气、心率、血压、呼吸等变化。结果BiPAP组治疗后,有效率97.3%。32例患者症状明显改善,血气分析及生命体征参数比较差异均有统计学意义(P<0.05)。对照组总有效率为83.2%。结论BiPAP无创通气治疗急性左心衰能迅速缓解症状,可作为治疗急性左心衰的一种安全、有效的方法。     

Adaptation to different noninvasive ventilation masks in critically ill patients

OBJECTIVE:

To identify which noninvasive ventilation (NIV) masks are most commonly used and the problems related to the adaptation to such masks in critically ill patients admitted to a hospital in the city of São Paulo, Brazil.

METHODS:

An observational study involving patients ≥ 18 years of age admitted to intensive care units and submitted to NIV. The reason for NIV use, type of mask, NIV regimen, adaptation to the mask, and reasons for non-adaptation to the mask were investigated.

RESULTS:

We evaluated 245 patients, with a median age of 82 years. Acute respiratory failure was the most common reason for NIV use (in 71.3%). Total face masks were the most commonly used (in 74.7%), followed by full face masks and near-total face masks (in 24.5% and 0.8%, respectively). Intermittent NIV was used in 82.4% of the patients. Adequate adaptation to the mask was found in 76% of the patients. Masks had to be replaced by another type of mask in 24% of the patients. Adequate adaptation to total face masks and full face masks was found in 75.5% and 80.0% of the patients, respectively. Non-adaptation occurred in the 2 patients using near-total facial masks. The most common reason for non-adaptation was the shape of the face, in 30.5% of the patients.

CONCLUSIONS:

In our sample, acute respiratory failure was the most common reason for NIV use, and total face masks were the most commonly used. The most common reason for non-adaptation to the mask was the shape of the face, which was resolved by changing the type of mask employed.